Hydrafinil Myristate – Powder, 5g
$69.99
-
Hydrafinil Myristate – Powder, 5g is a high-purity laboratory-grade research compound in off-white to white crystalline powder form, functioning as the myristate ester derivative of hydrafinil (9-fluorenol), serving as a modified eugeroic wakefulness-promoting agent with enhanced lipophilicity and potential pro-drug characteristics compared to parent hydrafinil, available for fast, compliant shipping to all U.S. states and European countries.
-
Third-party lab-tested with public lot-coded certificates of analysis verifying ≥98–99% purity for absolute transparency
-
Formulation completely free of adulterants, excipients, and flow agents – 100% raw chemical ingredient
-
Precision over-weighed by 5–10% to compensate for natural adhesion loss during laboratory transfer and reconstitution
-
Glass vial with tamper-proof seal engineered for safe international transit and storage stability at room temperature
-
Hydrafinil Myristate – Powder, 5g
This premium laboratory-grade research compound is supplied as ultra-pure raw lyophilized powder with off-white to white crystalline appearance, engineered for modern scientific investigations requiring precise eugeroic (wakefulness-promoting) pharmacology with enhanced lipophilic properties. Hydrafinil Myristate is the myristate ester derivative of hydrafinil (9-fluorenol), representing a structurally modified analog that combines the wakefulness-promoting eugeroic activity of hydrafinil with enhanced lipophilicity from the myristate (C14 fatty acid) esterification, potentially serving as a pro-drug with altered bioavailability and metabolic characteristics compared to parent hydrafinil, making it a valuable tool for in vitro/in vivo modeling of alertness pathways, comparative pharmacology of ester-modified eugeroic compounds, and neurochemical research.
All domestic orders ship directly from primary United States production facilities, ensuring rapid delivery to all 50 U.S. states. International orders to the UK and continental Europe are fulfilled through our dedicated United Kingdom shipping hub, enabling seamless, efficient customs clearance across European borders without delay.
-
Lot-coded containers with publicly accessible third-party HPLC/LC-MS lab reports verifying specification ≥98% purity for absolute transparency
-
Formulation completely free of adulterants, excipients, and flow agents to guarantee raw chemical purity
-
Strategic over-weighing inside the vessel compensates for natural adhesion loss during laboratory transfer
-
Packaging engineering utilizes a glass vial with tamper-proof seal to maintain chemical stability during transit and room temperature storage
Technical Specifications & Chemical Profile
| Chemical Property | Specification Data |
|---|---|
| Product Name | Hydrafinil Myristate – Powder, 5g |
| Common Synonyms | 9-Fluorenol Myristate, Hydrafinil-Myristate, 9-Hydroxyfluorene Myristate Ester, 9H-fluoren-9-ol myristate, Fluoren-9-ol myristate, Myristic acid 9-fluorenol ester, C.sub.?.H.sub.?O.sub.? (myristate ester derivative) |
| CAS Number | 1689-64-1 (parent Hydrafinil/9-Fluorenol) |
| Molecular Formula | C₂₇H₄₀O₂ (estimated: C₁₃H₁₀O + C₁₄H₂₈O₂ – H₂O) |
| Molar Mass | 400.62 g/mol (estimated: 182.22 + 228.37 – 18.02) |
| Primary Target Mechanism | Myristate ester derivative of hydrafinil (9-fluorenol); eugeroic wakefulness-promoting agent; 5-HT₆ receptor antagonist; potential pro-drug with enhanced lipophilicity and altered bioavailability compared to parent hydrafinil; weak dopamine reuptake inhibition |
| Physical Form | Off-white to white crystalline powder |
Research Applications & Storage Protocols
Myristate Ester Eugenoric Pro-Drug Profile
Hydrafinil Myristate functions as the myristate ester derivative of hydrafinil (9-fluorenol), representing a structurally modified analog that combines the eugeroic wakefulness-promoting activity of hydrafinil with enhanced lipophilicity from myristate (C14 fatty acid) esterification. This esterification likely serves to create a pro-drug with altered bioavailability, increased membrane permeability, and potentially modified metabolic characteristics compared to parent hydrafinil, the C14 chain providing enhanced lipophilicity that may improve tissue distribution and CNS penetration. The myristate ester may also enhance stability and reduce metabolic degradation, making Hydrafinil Myristate valuable for investigators studying comparative pharmacology of ester-modified eugeroic compounds, lipophilicity-enhanced drug delivery, wakefulness mechanisms, vigilant enhancement, fatigue reduction, and dopaminergic signaling pathways in in vitro and in vivo experimental models.
Handling & Storage Guidelines
-
Long-Term Storage: Store at room temperature, tightly sealed, away from heat, light and moisture; similar to parent hydrafinil recommended storage conditions
-
Solubility: Enhanced lipophilicity due to myristate ester; expected soluble in chloroform, methanol, and other organic solvents; improved membrane permeability compared to parent hydrafinil
-
Appearance: Off-white to white crystalline powder, similar to parent hydrafinil appearance
Global Logistics & Order Fulfillment
We proudly support scientific advancement across all 50 U.S. states and throughout Europe. Customers can seamlessly toggle their preferred currency between USD and EUR using the currency switcher located on the left-hand side of our website. All shipments are securely packaged to withstand international transit without compromising structural or chemical stability.
Laboratory Use Only Disclaimer
This material is sold strictly for laboratory research and development use only. It is not approved for human consumption, nor for medical, veterinary, or household applications. All purchases are governed by our standard Terms & Conditions. Please review them carefully before placing your order.
| pa_feature |
Discountinued |
|---|---|
| pa_form |
Powders |
| pa_types |
Afinils |
You must be logged in to post a review.


Reviews
There are no reviews yet.